Eucalyptus Oil for Cough Relief

Research suggests that eucalyptus oil and its primary active compound, 1,8-cineole (eucalyptol), show consistent promise for relieving cough and related upper respiratory symptoms, with supporting evidence drawn from multiple narrative reviews, mechanistic studies, and at least one exploratory clinical trial. Studies indicate that eucalyptol exerts anti-inflammatory, mucus-thinning, and bronchodilatory effects through identifiable biological pathways, and one 2024 open-label trial found that early cineole supplementation was associated with meaningfully reduced disease burden and faster recovery from the common cold compared to delayed use. Topical formulations containing eucalyptus alongside menthol and camphor have also appeared in treatment reviews for children's cold symptoms, and a 2025 randomized trial found that eucalyptol-containing capsules added to standard therapy modestly improved sinus and cough outcomes in patients with chronic rhinosinusitis. That said, the body of evidence relies heavily on narrative reviews rather than large randomized controlled trials, objective measures of benefit are sometimes lacking or do not match subjective improvements, and researchers consistently note that questions around optimal formulation, delivery, and safety — particularly in sensitive populations — warrant further investigation before firm conclusions can be drawn.